Metraipolis › archive › dc_feb5949a9a2e

Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancer — Europe PMC PMID:42185502

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42185502
DOI
10.1007/s00535-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-01T08:31:32.601Z
SHA-256 of the archived text
0f25d5a4aa505fb7290068d9369b8fb7f790108db7baa78974fff3b29d9fb9b0
Stable URL of this page
https://metraipolis.com/documento/dc_feb5949a9a2e

How to cite

Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancer — Europe PMC PMID:42185502 — Europe PMC (en), https://europepmc.org/article/MED/42185502 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_feb5949a9a2e (Metraipolis archive dc_feb5949a9a2e, sha256 0f25d5a4aa505fb7290068d9369b8fb7f790108db7baa78974fff3b29d9fb9b0)
BibTeX
@misc{dcfeb5949a9a2e,
  title = {Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancer — Europe PMC PMID:42185502},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42185502},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_feb5949a9a2e; sha256 0f25d5a4aa505fb7290068d9369b8fb7f790108db7baa78974fff3b29d9fb9b0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42185502. Agents can read the archived copy with the MCP tool read_document.